Species-Specific Therapy of Acute Lymphoid Leukemia

  • D. Pinkel
Conference paper
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 32)

Abstract

Forty years ago, Farber and associates described temporary remissions of acute leukemia in children produced by folic acid antagonists [13]. This ignited the hope that this most frequent and always fatal childhood cancer might be curable by drugs. Twenty years ago, Aur and associates completed accession of patients to total therapy study V, the first treatment protocol to result in 50% cure of acute lymphoid leukemia (ALL) [3]. Their results stand 20 years later (Fig. 1), and have been reproduced throughout the world in many thousands of children [6]. More important, recent national vital statistics of the United States and the United Kingdom indicate a 50% reduction in childhood leukemia mortality [4, 29]. Further, the cured children generally enjoy a normal life-style without need for medication.

Keywords

Lymphoma Leukemia Methotrexate Cyclophosphamide Prednisone 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Amylon M, Murphy S, Pullen J etal. (1988) Treatment of lymphoid malignancies according to immune phenotype: Preliminary results in T-cell disease ( Abstr ). Proc Am Soc Clin Oncol 7: 225Google Scholar
  2. 2.
    Aur RJA, Simone JV, Pratt CB etal. (1971) Successful remission induction in children with acute lymphocytic leukemia at high risk for treatment failure. Cancer 27: 1332–1336PubMedCrossRefGoogle Scholar
  3. 3.
    Aur RJA, Simone JV, Hustu HO et al. (1971) Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia. Blood 37: 272–281PubMedGoogle Scholar
  4. 4.
    Birch JM, Marsden HB, Jones PH et al. (1988) Improvements in survival from childhood cancer: results of a population based survey over 30 years. Br Med J 296: 1372–1376CrossRefGoogle Scholar
  5. 5.
    Camitta BM, Pinkel D, Thatcher G et al. (1980) Failure of early intensive chemotherapy to improve prognosis in childhood acute lymphocytic leukemia. Med Pediatr Oncol 8: 383–389PubMedCrossRefGoogle Scholar
  6. 6.
    Crist WM, Furman W, Strother D et al. (1987) Acute lymphocytic leukemia in childhood: Immunologic marker, cytoge-netic, and molecular studies. South Med J 80: 841–847PubMedCrossRefGoogle Scholar
  7. 7.
    Croce CM (1986) Chromosome translocations and human cancer. Cancer Res 46: 6019–6023PubMedGoogle Scholar
  8. 8.
    Denny CT, Hollis GF, Hecht F etal. (1986) Common mechanism of chromosome inversion in B-and T-cell tumors: Relevance to lymphoid development. Science 234: 197–200PubMedCrossRefGoogle Scholar
  9. 9.
    Dowell BL, Borowitz MJ, Boyett JM et al. (1987) Immunologic and clinieopathologic features of common acute lymphoblastic leukemia antigen-positive childhood T-cell leukemia. Cancer 59: 2020 - 2026PubMedCrossRefGoogle Scholar
  10. 10.
    Dube ID, Raimondi SC, Pi D et al. (1986) A new translocation, t(10;14) (q24;qll), in T celi neoplasia. Blood 67: 1181–1184PubMedGoogle Scholar
  11. 11.
    Erikson J, Finger L, Sun L etal. (1986) Deregulation of c-myc by translocation of the a-locus of the T-cell receptor in T-cell leukemias. Science 232: 884–886PubMedCrossRefGoogle Scholar
  12. 12.
    Farber S, Toch R, Sears EM, Pinkel D (1956) Advances in chemotherapy of cancer in man. Adv Cancer Res 4: 1–71PubMedCrossRefGoogle Scholar
  13. 13.
    Farber S, Diamond LK, Mercer RD et al. (1948) Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin). N Engl J Med 238: 787–793PubMedCrossRefGoogle Scholar
  14. 14.
    Feickert HJ, Göbel U, Ludwig W et al. (1987) Childhood acute lymphoblastic leukemia of B-cell type: Trials ALL-BFM 81 and ALL-BFM 83 ( Abstr ). Proc Am Soc Clin Oncol 6: 149Google Scholar
  15. 15.
    Flandrin G, Brouet JC, Daniel MT et al. (1975) Acute leukemia with Burkitt’s tumor cells: A study of six cases with special reference to lymphocyte surface markers. Blood 45: 183–188PubMedGoogle Scholar
  16. 16.
    Finger LR, Harvey RC, Moore RC et al. (1986) A common mechanism of chromosomal translocation in T-and B-cell neoplasia. Science 234: 982–985PubMedCrossRefGoogle Scholar
  17. 17.
    Frankel LS, Ochs J, Shuster J et al. (1987) Pilot protocol improves remissions for infant leukemia and provides detailed laboratory characterization ( Abstr ). Proc Am Soc Clin Oncol 6: 161Google Scholar
  18. 18.
    Gale RP (1979) Advances in the treatment of acute myelogenous leukemia. N Engl J Med 300: 1189–1199PubMedCrossRefGoogle Scholar
  19. 19.
    Goyns MH, Hann IM, Stewart J etal. (1987) The c-ets-1 proto-oncogene is rear-ranged in some cases of acute lymphoblastic leukaemia. Br J Cancer 56: 611–613PubMedCrossRefGoogle Scholar
  20. 20.
    Hurwitz CA, Loken MR, Graham ML, etal. (1988) Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. Blood 72: 299–307PubMedGoogle Scholar
  21. 21.
    Jolivet J, Cole D, Holcenberg JS etal. (1984) L-asparaginase (L-ASP) antagonism of methotrexate ( MTX) cytotoxicity: An alternative explanation (Abstr). Proceedings of the American Association for Cancer Research 25: 309Google Scholar
  22. 22.
    Kaneko Y, Maseki N, Takasaki N et al. (1986) Clinical and hematologic characteristics in acute leukemia with llq23 translocations. Blood 67: 484–491PubMedGoogle Scholar
  23. 23.
    Katz F, Malcolm S, Gibbons B etal (1988) Cellular and molecular studies on infant null acute lymphoblastic leukemia. Blood 71: 1438–1447PubMedGoogle Scholar
  24. 24.
    Kurzrock R, Blick MB, Talpaz M et al. (1986) Rearrangement in the breakpoint cluster region and the clinical course in Philadelphia-negative chronic myelogenous leukemia. Ann Intern Med 105: 673–679PubMedGoogle Scholar
  25. 25.
    Lampert F, Harbott J, Ritterbach J et al. (1988) T-cell acute childhood lymphoblastic leukemia with chromosome 14qll anomaly: a morphologic, immunologic, and cytogenetic analysis of 10 patients. Blut 56: 117–123PubMedCrossRefGoogle Scholar
  26. 26.
    Lauer SJ, Pinkel D, Buchanan GR et al. (1987) Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Cancer 60: 2366–2371PubMedCrossRefGoogle Scholar
  27. 27.
    Lipshultz SE, Colan SD, Sanders SP et al. (1987) Late cardiac effects of doxorubicin in childhood acute lymphoblastic leukemia (ALL) (Abstr). Proceedings of the American Society of Hematology, 234 aGoogle Scholar
  28. 28.
    Luster AD, Jhanwar SC, Chaganti RSK etal. (1987) Interferon-inducible gene maps to a chromosomal band associated with a (4; 11) translocation in acute leukemia cells. Proc Natl Acad Sci, USA 84: 2868–2871PubMedCrossRefGoogle Scholar
  29. 29.
    Miller RW, McKay FW (1984) Decline in US childhood cancer mortality 1950 through 1980. JAMA 251: 1567–1570PubMedCrossRefGoogle Scholar
  30. 30.
    Patte C, Philip T, Rodary C et al. (1986) Improved survival rate in children with Stage III and IV B cell non-Hodgkin’s lymphoma and leukemia using multiagent chemotherapy: Results of a study of 114 children from the French Pediatric Oncology Society. J Clin Oncol 4: 1219–1226PubMedGoogle Scholar
  31. 31.
    Pedersen-Bjergaard J, Ersboll J, Hansen VL et al. (1988) Carcinoma of the urinary bladder after treatment with cyclophos-phamide for non-Hodgkin’s lymphoma. N Engl J Med 318: 1028–1032PubMedCrossRefGoogle Scholar
  32. 32.
    Pinkel D (1979) Treatment of childhood acute lymphocytic leukemia. Modern Trends in Human Leukemia III. R Neth, RC Gallo, P-H Hofschneider and K Mannweiler (eds). pp 25–33. New YorkCrossRefGoogle Scholar
  33. 33.
    Pinkel D (1985) Current issues in the management of children with acute lymphocytic leukaemia. Postgrad Med J 61: 93–102PubMedCrossRefGoogle Scholar
  34. 34.
    Pinkel D (1987) Curing children of leukemia. Cancer 59: 1683–1691PubMedCrossRefGoogle Scholar
  35. 35.
    Pui C-H, Williams DL, Kalwinsky DK etal. (1986) Cytogenetic features and serum lactic dehydrogenase level predict a poor treatment outcome for children with pre-B-cell leukemia. Blood 67: 1688–1692PubMedGoogle Scholar
  36. 36.
    Raimondi SC, Pui CH, Behm FG et al. (1987) 7q32–q36 Translocations in child-hood T cell leukemia: Cytogenetic evidence for involvement of the T cell recep-tor ß-chain gene. Blood 69: 131–134PubMedGoogle Scholar
  37. 37.
    Rivera GK, Mauer AM (1987) Contro-versies in the management of childhood acute lymphoblastic leukemia: treatment intensification, CNS leukemia, and prognostic factors. Semin Hematol 24: 12–26PubMedGoogle Scholar
  38. 38.
    Rowley JD (1979) Chromosome abnor-malities in leukemia. Modern Trends in Human Leukemia III. R Neth, RC Gallo, P-H Hofschneider and K Mannweiller (eds.). pp 43–52. New YorkCrossRefGoogle Scholar
  39. 39.
    Rubin CM, Carrino JJ, Dickler MN et al. (1988) Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia. Proc Natl Acad Sci USA 85: 2795–2799PubMedCrossRefGoogle Scholar
  40. 40.
    Sansone R, Strigini P (1988) Infantile leukemia with a new chromosomal rear-rangement involving llq. Cancer Genet Cytogenet 32: 293–294PubMedCrossRefGoogle Scholar
  41. 41.
    Sandberg AA (1986) The chromosomes in human leukemia. Semin Hematol 23: 201–217PubMedGoogle Scholar
  42. 42.
    Schabel FM Jr, Skipper HE, Trader MW et al. (1974) Combination chemotherapy for spontaneous AKR lymphoma. Cancer Chemotherapy Reports 4: 53–70Google Scholar
  43. 43.
    Sen L, Borella L (1975) Clinical importance of lymphoblasts with T markers in childhood acute leukemia. N Engl J Med 292: 828–832PubMedCrossRefGoogle Scholar
  44. 44.
    Stam K, Heisterkamp N, Grosveld G et al. (1985) Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome. N Engl J Med 313: 1429–1433PubMedCrossRefGoogle Scholar
  45. 45.
    Stass SA, Mirro J Jr (1986) Lineage heterogeneity in acute leukaemia: Acute mixed-lineage leukaemia and lineage switch. Clin Haematol 15: 811–827PubMedGoogle Scholar
  46. 46.
    Steinherz PG, Gaynon P, Miller DR et al. (1986) Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen-A new intensive therapy protocol: A report from the Childrens Cancer Study Group. J Clin Oncol 4: 744–752PubMedGoogle Scholar
  47. 47.
    Sullivan MP, Ramirez I (1982) Contribution of cytosar to T-antigen positive lymphoid disease control in children given 2nd generation LSA2L2 therapy. Proc Am Assoc Cancer Res 23: 114Google Scholar
  48. 48.
    Sunami S, Fuse A, Simizu B et al. (1987) The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down’s Syndrome. Blood 70: 368–371PubMedGoogle Scholar
  49. 49.
    Williams DL, Tsiatis A, Brodeur GM etal. (1982) Prognostic importance of chromosome number in 136 untreated children with acute lymphoblastic leukemia. Blood 60: 864–871PubMedGoogle Scholar
  50. 50.
    Yang-Feng TL, Francke U, Ullrich A (1985) Gene for human insulin receptor: Localization to site on chromosome 19 involved in pre-B-cell leukemia. Science 228: 728–730PubMedCrossRefGoogle Scholar
  51. 51.
    Zuelzer WW, Flatz G (1960) Acute child-hood leukemia: A ten-year study. Am J Dis Child 100: 886–907PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • D. Pinkel
    • 1
  1. 1.Dept. of PediatricsUniversity of Texas M.D. Anderson Cancer CenterUSA

Personalised recommendations